Latest Industry Insights
Industry Insight
Next-Generation Sequencing for SARS-CoV-2 Surveillance
To gain some insights into the role of NGS in global SARS-CoV-2 surveillance, we spoke to Michelle Fraser, general manager, NGS for PerkinElmer. Michelle also explains how labs working in this area can increase their throughput, decrease associated costs and simplify the analysis of NGS data collected.
Industry Insight
Harnessing T Cells To Detect Disease
In this interview, Dr Sudeb Dalai, senior medical director at Adaptive Biotechnologies, discusses the role that T-cell analysis may play in the diagnosis and treatment of diseases including SARS-CoV-2.
Industry Insight
Lateral Flow Assay Development
Here we summarize the webinar that was hosted by Klaus Hochleitner, PhD., which provides an overview of the important factors and considerations for robust lateral flow assay development.
Industry Insight
Detecting Residual Cancer Using Whole-Genome Sequencing and Artificial Intelligence
When a tumor is surgically removed, small amounts of residual cancer can remain at a level that is undetectable with current imaging or blood-based approaches. In this interview, Technology Networks spoke with Asaf Zviran, co-founder and CEO of C2i Genomics to find out more about the company’s C2-Intelligence Platform for the detection of trace amounts of cancer.
Industry Insight
Ingestible Technologies for Diagnosis of Gastrointestinal Disorders
Progenity’s Christopher Wahl provides his insights into the research and work being done specifically with Progenity’s novel ingestible lab-in-a-capsule, PIL Dx.
Industry Insight
How Can Informatics Make the Post-COVID Workplace Safe and Secure?
As COVID-19 vaccination programs kick into gear, private and public workplaces are weighing up the risks and benefits of asking employees to return to the office. Affinity Empowering Inc, who offer workplace eHealth compliance services, have rolled out an end-to-end COVID-19 testing program to assist employers in their return to work protocols. We spoke to Affinity CEO Scott Storrer to find out more.
Industry Insight
Using Rapid Antigen Tests To Fight SARS-CoV-2
Technology Networks recently interviewed Anthony V. Lemmo, to learn how rapid antigen tests work, how they compare to PCR tests and how they can be used to help slow the spread of SARS-CoV-2.
Industry Insight
Tackling the Spread of SARS-CoV-2 Variants
Public health groups and leaders around the world are adopting different approaches for viral tracking and monitoring to halt the spread of novel SARS-CoV-2 variants.
Industry Insight
A Skin Test To Measure T-Cell Immunity to SARS-CoV-2
Technology Networks recently had the pleasure of speaking to Seth Lederman, president and chief executive officer of Tonix Pharmaceuticals, to learn more about the T-cell response to SARS-CoV-2, how it compares to the antibody response and the importance of measuring it during the pandemic.
Industry Insight
Combining AI and Point-of-Care Diagnostics for Rapid COVID-19 Screening
Technology Networks interviewed Dr Andrew Soltan, NIHR Academic Clinical Fellow at the John Radcliffe Hospital, to learn more about the CURIAL algorithm and how it is being used alongside Sight OLO, Sight Diagnostics’ machine vision-based blood analyzer, to rapidly triage patients and support infection control within hospitals.
Advertisement